← Snapshot 21

Orange Book snapshot 21: Products

Products page 143 of 799 · 39,901 matching rows.

Source row, Application type, Application number table
Source rowApplication typeApplication numberProduct numberIngredient rawDosage form / route rawDosage formRouteTrade nameApplicantStrength rawTE rawTE JSONApproval dateApproval date rawApproved before 1982RLDRSProduct typeApplicant full nameRaw row SHA-256
7102A206144001CEFIXIMEFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFIXIMESANDOZ INC100MG/5ML[]2017-11-17Nov 17, 2017NoNoNoDISCNSANDOZ INC7502ccc8fda9885bd1076699c2ff4ff03d6b6c5f28532d6d54e8a51e281a828b
7103A206144002CEFIXIMEFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFIXIMESANDOZ INC200MG/5ML[]2017-11-17Nov 17, 2017NoNoNoDISCNSANDOZ INC887ed64b43293a6009c2b370e4f94d10c52e560a1c04ed6ccf5e533275ae5cd9
7104A065409001CEFPODOXIME PROXETILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPODOXIME PROXETILAUROBINDO PHARMA LTDEQ 50MG BASE/5ML[]2007-06-08Jun 8, 2007NoNoNoRXAUROBINDO PHARMA LTDa0d4a7222ab4bece4e7aa23403fa1132ffcadf5a50ede39f2ec8705447459d78
7105A065409002CEFPODOXIME PROXETILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPODOXIME PROXETILAUROBINDO PHARMA LTDEQ 100MG BASE/5ML[]2007-06-08Jun 8, 2007NoNoYesRXAUROBINDO PHARMA LTD74e681ac0cb1082819e6f047579c078e18b0ba8824c56dd073469ebeaef05aa1
7106A090031001CEFPODOXIME PROXETILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPODOXIME PROXETILSANDOZEQ 50MG BASE/5ML[]2009-01-14Jan 14, 2009NoNoNoDISCNSANDOZ INC507f5f5960e47dd0f6aa78305debcf44035c706edbb4a4f62e8987a130856b0d
7107A090031002CEFPODOXIME PROXETILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPODOXIME PROXETILSANDOZEQ 100MG BASE/5ML[]2009-01-14Jan 14, 2009NoNoNoDISCNSANDOZ INCeaf263d12785453331c0318116ca2285ecb6f6d7f657b61d442096cfc1805aef
7108A065082001CEFPODOXIME PROXETILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPODOXIME PROXETILSUN PHARM INDS LTDEQ 50MG BASE/5ML[]2002-05-31May 31, 2002NoNoNoDISCNSUN PHARMACEUTICAL INDUSTRIES LTDed7462e6710a9ee05f78764341171b246bc0fae3906069fe7f33a6b351b7ebf9
7109A065082002CEFPODOXIME PROXETILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPODOXIME PROXETILSUN PHARM INDS LTDEQ 100MG BASE/5ML[]2002-05-31May 31, 2002NoNoNoDISCNSUN PHARMACEUTICAL INDUSTRIES LTDf1bc9831e12fc2264be2ea5213a5d05d451936ab556f61b6102c82c0e863b64a
7110A065351001CEFPROZILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPROZILAPOTEX INC125MG/5MLAB["AB"]2012-02-29Feb 29, 2012NoNoNoRXAPOTEX INC8b52f4241b89aaccbe65aac103c671f910a0d855a650af47db15a48121475740
7111A065351002CEFPROZILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPROZILAPOTEX INC250MG/5MLAB["AB"]2012-02-29Feb 29, 2012NoNoNoRXAPOTEX INC6727e48b4fcbfce3db25e3e41a15288fa9ea2a157d6908eef62dfd8a92b8b72c
7112A065381001CEFPROZILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPROZILAUROBINDO PHARMA125MG/5MLAB["AB"]2007-01-30Jan 30, 2007NoNoNoRXAUROBINDO PHARMA LTD2cee2b0fa7742bc8ee553cba2a936c6f16997a6a2b571ff4c5685d88fc1330d4
7113A065381002CEFPROZILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPROZILAUROBINDO PHARMA250MG/5MLAB["AB"]2007-01-30Jan 30, 2007NoNoNoRXAUROBINDO PHARMA LTDc5f1b3c1bdf279dc422aa8b677f45160eb5bacc8cc850388cfb034eb8018417a
7114A065261001CEFPROZILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPROZILLUPIN125MG/5MLAB["AB"]2005-12-19Dec 19, 2005NoNoNoRXLUPIN LTD78a05ad94b6903a1b4fef3ed564bba20656632c6e2196d78606ea681d7b59b53
7115A065261002CEFPROZILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPROZILLUPIN250MG/5MLAB["AB"]2005-12-19Dec 19, 2005NoNoYesRXLUPIN LTDe2ef71b32247ee628ae82cac5f724ff32440d6ebb767b5dd8c0b6ee5b4e86eef
7116A065284002CEFPROZILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPROZILORCHID HLTHCARE125MG/5MLAB["AB"]2005-12-30Dec 30, 2005NoNoNoRXORCHID HEALTHCAREcd88437279a56950f24336a88b782595d6ea39f6c88c7485635ad2804eb795e0
7117A065284001CEFPROZILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPROZILORCHID HLTHCARE250MG/5MLAB["AB"]2005-12-30Dec 30, 2005NoNoNoRXORCHID HEALTHCARE60d96671c44aae36027917216387607b6c0d50c43e3b6cfb9e17a76275ab8193
7118A065202001CEFPROZILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPROZILRANBAXY LABS LTD125MG/5ML[]2006-06-30Jun 30, 2006NoNoNoDISCNRANBAXY LABORATORIES LTDefe1e4151d6d49aa65ad3c11f00a93fc809162daaaa009b1bea430b90b43b2a4
7119A065202002CEFPROZILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPROZILRANBAXY LABS LTD250MG/5ML[]2006-06-30Jun 30, 2006NoNoNoDISCNRANBAXY LABORATORIES LTDd4794c19da27945f5eac008d4fd29367764885cba4e9c7e32093adbbdc26d13d
7120A065257001CEFPROZILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPROZILSANDOZ125MG/5MLAB["AB"]2005-12-08Dec 8, 2005NoNoNoRXSANDOZ INCc96785bfeb79be686b2bfd37f8ed9417ee32d6cb63650bd45f1b7c4f0b27d77d
7121A065257002CEFPROZILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPROZILSANDOZ250MG/5MLAB["AB"]2005-12-08Dec 8, 2005NoNoNoRXSANDOZ INC49fc501e35f68e2f6cf5bc5c9cb6919755ab2f69836af6ed6efcc15b28222cbc
7122A065236001CEFPROZILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPROZILTEVA PHARMS125MG/5ML[]2005-12-08Dec 8, 2005NoNoNoDISCNTEVA PHARMACEUTICALS USA212d3cd19415ff5f050dd483a1bf75c31a279637d5838f2f53b5f2bde9ef4c07
7123A065236002CEFPROZILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFPROZILTEVA PHARMS250MG/5ML[]2005-12-08Dec 8, 2005NoNoNoDISCNTEVA PHARMACEUTICALS USA9ac86178be998d11b0ee644accace897ee1f4b7b5832d91781a24f3078b8fe58
7124N050672001CEFUROXIME AXETILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFTINGLAXOSMITHKLINEEQ 125MG BASE/5ML[]1994-06-30Jun 30, 1994NoYesNoDISCNGLAXOSMITHKLINE4965b9447d3acb4f7aec57116474d74a73a6bad274322433eb73c8bf4c978d24
7125N050672002CEFUROXIME AXETILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFTINGLAXOSMITHKLINEEQ 250MG BASE/5ML[]1997-04-29Apr 29, 1997NoYesNoDISCNGLAXOSMITHKLINE2758cabbfbdda415940ad5ffc0a81b64773e5a21e143eb1e6ff5abf43fd4d943
7126A065323001CEFUROXIME AXETILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFUROXIME AXETILSUN PHARM INDS LTDEQ 125MG BASE/5ML[]2008-02-05Feb 5, 2008NoNoNoDISCNSUN PHARMACEUTICAL INDUSTRIES LTDd860b0b7603ce665c32c9d01a23e006414c6ea901ea9a0c907b86ae44a2db8c6
7127A065323002CEFUROXIME AXETILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFUROXIME AXETILSUN PHARM INDS LTDEQ 250MG BASE/5ML[]2008-02-05Feb 5, 2008NoNoNoDISCNSUN PHARMACEUTICAL INDUSTRIES LTDcef4d9d48b11eedae1dec8b52046af0d6485a84f840faca6861ebf7acbfd9725
7128N050665001CEFPROZILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFZILCORDEN PHARMA125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]1991-12-23Dec 23, 1991NoYesNoDISCNCORDEN PHARMA LATINA SPA174794491012eb25241b89f08a2ce24a20443c5d5ab9b8aa1dac9c111ecb8992
7129N050665002CEFPROZILFOR SUSPENSION;ORALFOR SUSPENSIONORALCEFZILCORDEN PHARMA250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]1991-12-23Dec 23, 1991NoYesNoDISCNCORDEN PHARMA LATINA SPAe453390630021f1bf93f9f1b3e6292d260a861a908fcf9fca85268063313bb63
7130A210221001CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINALKEM LABS LTDEQ 125MG BASE/5MLAB["AB"]2019-03-26Mar 26, 2019NoNoNoRXALKEM LABORATORIES LTDa33ab6daead60666586d0d4312b344d2cf86efd49b892cb4d11ee8c4f885787b
7131A210221002CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINALKEM LABS LTDEQ 250MG BASE/5MLAB["AB"]2019-03-26Mar 26, 2019NoNoNoRXALKEM LABORATORIES LTD59f2f7c8e04971303299a5192b8eb0b10cac1be38920f08dc1df3d13dfeeb45e
7132A062986001CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINAPOTHECONEQ 125MG BASE/5ML[]1991-04-18Apr 18, 1991NoNoNoDISCNAPOTHECON INC DIV BRISTOL MYERS SQUIBB81cde727da0e2c549bca3019898b56f930f7a609f3ff7c326fe4370ad5cf5463
7133A062987001CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINAPOTHECONEQ 250MG BASE/5ML[]1989-07-25Jul 25, 1989NoNoNoDISCNAPOTHECON INC DIV BRISTOL MYERS SQUIBB577556878e044227b34461f07f56ace3da0b663f13a337d6030e74496fd72282
7134A062778001CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINBARREQ 125MG BASE/5ML[]1987-08-06Aug 6, 1987NoNoNoDISCNBARR LABORATORIES INC000dce0aebee1f02b9d9c8c033fe903561b90c9604e57d3f603a07f586dd0452
7135A062777001CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINBARREQ 250MG BASE/5ML[]1987-08-06Aug 6, 1987NoNoNoDISCNBARR LABORATORIES INC360f06e2f82bfb0c0830076224929031eb1c2c97a6f3c55bbcf6d01682fcb377
7136A062117001CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINFACTA FARMAEQ 100MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons*[]Approved Prior to Jan 1, 1982YesNoNoDISCNFACTA FARMACEUTICI SPA2a9c77346baeeba0e0ed2c4310f2e082bd783f4d9d083b0405b130d7c73810d6
7137A062117002CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINFACTA FARMAEQ 125MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons*[]Approved Prior to Jan 1, 1982YesNoNoDISCNFACTA FARMACEUTICI SPA2bfb8a5db8006093a79344315b1157b7eca203198b1fdf0f7f2dec9d05f06795
7138A062117003CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINFACTA FARMAEQ 250MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons*[]Approved Prior to Jan 1, 1982YesNoNoDISCNFACTA FARMACEUTICI SPA29bd40d7a744272a1b83f360f658579e19304e3d7351eb7a50ba1c785c756c40
7139A065444001CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINHIKMA PHARMSEQ 125MG BASE/5ML[]2009-08-28Aug 28, 2009NoNoNoDISCNHIKMA PHARMACEUTICALS53f1d6d337e30b59023a58a1312d78c4e4919a5e66da52649a96908bf33cc2e4
7140A065444002CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINHIKMA PHARMSEQ 250MG BASE/5ML[]2009-08-28Aug 28, 2009NoNoNoDISCNHIKMA PHARMACEUTICALS69a8ebd0da4c3cc43b2e3d1a248e4bae76d3bdc5ed0cd7d168f938b7e8885043
7141A065234001CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINLUPINEQ 125MG BASE/5MLAB["AB"]2005-08-17Aug 17, 2005NoNoNoRXLUPIN LTDbc9354b905e6e9a5001669604bce5d8813cf447a009c32f7235e6b6ebb5a5e7e
7142A065234002CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINLUPINEQ 250MG BASE/5MLAB["AB"]2005-08-17Aug 17, 2005NoNoNoRXLUPIN LTDe0240af66b9216e6b4d28c1f48b1ce38a0371a8fab70bfd7807180acc47d7aea
7143A065326001CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINORCHID HLTHCAREEQ 125MG BASE/5MLAB["AB"]2006-07-10Jul 10, 2006NoNoNoRXORCHID HEALTHCAREdfeb481df18233a7a31aecb5340e170d85fcdf140ee5711a7fcb05d77a1d24c7
7144A065326002CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINORCHID HLTHCAREEQ 250MG BASE/5MLAB["AB"]2006-07-10Jul 10, 2006NoNoNoRXORCHID HEALTHCAREef7b77ee13c95aa66bc0b0e2ef8313db2f43eecee694beee3e28958e9c6de441
7145A065081001CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINSUN PHARM INDS LTDEQ 125MG BASE/5ML[]2001-07-27Jul 27, 2001NoNoNoDISCNSUN PHARMACEUTICAL INDUSTRIES LTDfc54695ec4345199c12ae08bcb72164f07558f10d8727a55e4ab6ddeeee6ea65
7146A065081002CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINSUN PHARM INDS LTDEQ 250MG BASE/5ML[]2001-07-27Jul 27, 2001NoNoNoDISCNSUN PHARMACEUTICAL INDUSTRIES LTDc10ddb89035a21aa4010c241e370d6ffa67128917ab1acc0a2a807df5a70f8d5
7147A062703001CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINTEVAEQ 125MG BASE/5MLAB["AB"]1987-02-13Feb 13, 1987NoNoNoRXTEVA PHARMACEUTICALS USA INC9fd2e2a1a707bab572b2d6b2e4f9ac0fd575868dcf7242aae15ebf5a38dc7b77
7148A062767001CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINTEVAEQ 125MG BASE/5ML[]1987-06-16Jun 16, 1987NoNoNoDISCNTEVA PHARMACEUTICALS USA INC1309f3520b7b4242f926717e312d9d9a48ca82106721938cf42956daa13fd924
7149A062873001CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINTEVAEQ 125MG BASE/5ML[]1988-05-23May 23, 1988NoNoNoDISCNTEVA PHARMACEUTICALS USA INC59cef73125cfcc797fc5a329642122d98c6f42de6ba0c0872bda98bc09b0a9a1
7150A062703002CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINTEVAEQ 250MG BASE/5MLAB["AB"]1987-02-13Feb 13, 1987NoNoYesRXTEVA PHARMACEUTICALS USA INCc13d15ebc223f88ac18c232f1496ebe652ef7a7634926aba29111f570b31ce45
7151A062768001CEPHALEXINFOR SUSPENSION;ORALFOR SUSPENSIONORALCEPHALEXINTEVAEQ 250MG BASE/5ML[]1987-06-16Jun 16, 1987NoNoNoDISCNTEVA PHARMACEUTICALS USA INCbc663184966db1c6d2106e5317c8a8766714bb6e801db1164261b5c88e58d3e4